Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.
Clinical trial NCT02697474 · COMPLETED
Trial details
- NCT number
- NCT02697474
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.